ESR1 and systemic sclerosis: In order to evaluate whether the presence of anti-ERα antibodies plays a role in the clinical course of the disease, we divided SSc patients into subgroups according to the presence of serum anti-ERα antibodies and examined the demographic and clinical parameters in each group.